Logo

Life Technologies, Illumina Added to Nasdaq-100 Index

Dec 15, 2008
NEW YORK (GenomeWeb News) – Life Technologies and Illumina are among the firms that have been added to the Nasdaq-100 Index.
 
Both firms will be added to the index effective Dec. 22.
 
The Nasdaq-100 was established in January 1985 and represents the largest non-financial domestic and international securities listed on the Nasdaq based on market capitalization.
 
Life Technologies, formed by the recent merger of Invitrogen and Applied Biosystems, has a market cap of around $3.8 billion. Illumina’s market cap is roughly $2.7 billion.

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.